Follow us on:

943 506 061
Donostia-San Sebastián, Spain
8th -12th May 2022

María Jesús Vicent

Researcher unique identifier(s) (ORCID): 0000-0001-7771-3373

More information at and

Dr. María J. Vicent received her Ph.D. degree in 2001 in chemistry after her research on solid supports from the Universitat Jaume I (Castellon, Spain) after several scientific stays in the laboratory of Prof. Fréchet’s lab. at the University California (Berkeley, USA). María then moved into more biomedically-oriented research, initially with the Spanish company Instituto Biomar S.A., and subsequently at the Centre for Polymer Therapeutics at the University of Cardiff (UK) with Prof. R. Duncan after receiving a Marie Curie Postdoctoral Fellowship in 2002. In 2004, María joined the Centro de Investigación Príncipe Felipe (CIPF, Valencia, Spain) as a research associate through a Marie Curie Reintegration contract and was promoted to her current position as the head of the Polymer Therapeutics Laboratory at CIPF in 2006. María is currently responsible for the Screening Platform one of the Specialist Sites in the EU-OPENSCREEN European Research Infrastructure Consortium (ERIC) and coordinates the Advanced Therapies Program at the CIPF.

María’s research group focuses on the development of novel nanopharmaceuticals for different therapeutic and diagnostic applications - in particular the application of Polymer Therapeutics in unmet clinical needs. María has been funded by both national and European grants (several acting as coordinator, including an ERC Consolidator grant-MyNano and ERC-PoC-POLYIMMUNE, Fund Health La Caixa-NanoPanTher) from academia as well as industry. María has received several prizes, including the IVth and the IXth Idea Awards, and she has been elected as member of American Institute for Medical and Biological Engineering (AIMBE) College of Fellows Class of 2019. María has co-authored >110 peer-reviewed papers and ten patents. Three patents have been licensed to the pharmaceutical industry and a third used as the foundation for the founding of the spin-off company ‘Polypeptide Therapeutic Solutions S.L.’ (Valencia, Spain) in 2012. María was the President of the SPLC-CRS up to 2013 and the chairperson in key conferences in the nanomedicine field, such as the International Symposium on Polymer Therapeutics and the annual Controlled Release Society meeting in 2019. María is also the executive editor of Adv. Drug Deliv Rev, the associate editor of NanoMedicine: NBM and DDTR, and a member of the editorial boards of key journal in the field including, J. Control Rel., Polymer Chemistry, Biomaterial Sciences, and Mol. Pharmaceutics.


In GEP-SLAP 2022 we use our own and third party cookies to make sure everything works properly. For more information visit our cookie policy. You can accept all cookies by clicking on the "Accept" button or customize your choice by clicking on CONFIGURE OR REJECT.